Chairman Zhou Jie resigns just three months after taking on the role.

By selling its Wako chemicals unit, the top Japanese drugmaker Takeda could raise $1 billion for reinvestment in its pipeline.

Sanofi provided insight into the logistics hurdles faced by vaccine makers in China after a distribution and sales rule changed.

China's Shanghai Fosun Pharmaceuticals has reportedly won a bidding war for India's privately held injectable maker Gland Pharma in a rare cross-…

China Resources has teamed up with Australian investment bank Macquarie to buy a majority of cancer and cardio medical care provider GenesisCare in a $1.3…

China’s Jilin Zixin Pharmaceutical Industrial has splashed out $42 million to buy a Rhode Island-based high-definition genome mapping company, Nabsys 2.0.

Osaka-based Takeda Pharmaceutical is reviewing prospects to sell a majority stake in Wako Pure Chemical.

Management has offered to buy Beijing-based radiotherapy and diagnostic firm Concord Medical Services in a $228 million bid.